NCT07162987 Prehabilitation to Patients With Prostate Cancer
| NCT ID | NCT07162987 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Odense University Hospital |
| Condition | Prostate Cancer (Diagnosis) |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-08-04 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-08-04 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this feasibility study is to test a newly developed, multicomponent prehabilitation intervention to patients with prostate cancer, to improve their resilience to treatment side-effects. The main questions it aims to answer are: * Are patients and their close relatives willing to take part in prehabilitation? * What is the acceptability and feasibility of the prehabilitation intervention, seen from the perspectives of patients, their close relatives, and healthcare professionals? * Are the planned data collection methods feasible, and are there indications of a clinical effect? Participants will: * Take part in 12 weeks of physical exercise training * Attend a 4-day residential prehabilitation intervention, where they receive education and do exercises. After 12 weeks, it is possible to take part in a voluntary follow-up session. * Patients will respond to questionnaires about their health, symptoms, and quality of life. Patients and their close relatives will attend a group interview. Patients will also complete an exercise diary and brief physical tests
Eligibility Criteria
Inclusion Criteria: * Diagnosed with prostate cancer * min 18 years old * Treatment: Androgen deprivation therapy and raditation therapy * Resident in Vejle Municipality or Esbjerg Municipality * Can take part in residential prehabiliation in week 43 or 50, 2025, as well as physical exsercise training in the municipality * Willing to take part in a research study * Suited to take part in group sessions * Be able to read and be understood in Danish * Be responsible for own personal hygiene and medications at the 4-day residential stay Exclusion Criteria: * Persons who do not fulfil the inclusion criteria will be excluded
Frequently Asked Questions
Who can join the NCT07162987 clinical trial?
This trial is open to male participants only, aged 18 Years or older, studying Prostate Cancer (Diagnosis). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07162987 currently recruiting?
Yes, NCT07162987 is actively recruiting participants. Visit ClinicalTrials.gov or contact Odense University Hospital to inquire about joining.
Where is the NCT07162987 trial being conducted?
This trial is being conducted at Esbjerg, Denmark, Nyborg, Denmark, Vejle, Denmark.
Who is sponsoring the NCT07162987 clinical trial?
NCT07162987 is sponsored by Odense University Hospital. The trial plans to enroll 20 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.